Fortrea Holdings (FTRE) Other Non-Current Liabilities (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Other Non-Current Liabilities came in at $38.5 million in Q2 2026, up 4.05% on a YoY basis from $37.0 million in Q2 2025, and up 1.85% quarter-over-quarter from $37.8 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Other Non-Current Liabilities for 5 consecutive years, with $38.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Liabilities rose 4.05% year-over-year to $38.5 million; the trailing twelve-month figure through Jun 2026 stood at $38.5 million (up 4.05% YoY), and the FY2025 full-year result was $39.3 million, up 11.33% from the prior year.
- Other Non-Current Liabilities grew to $38.5 million in Q2 2026 per FTRE's latest filing, from $37.8 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $39.3 million in Q4 2025 and bottomed at $21.7 million in Q4 2022.
- Historically, Other Non-Current Liabilities has averaged $34.5 million across 5 years, with a median of $36.4 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities jumped 47.93% in 2023, then fell 20.0% in 2024.
- Over 5 years, Other Non-Current Liabilities stood at $21.7 million in 2022, then surged by 47.93% to $32.1 million in 2023, then climbed by 9.97% to $35.3 million in 2024, then climbed by 11.33% to $39.3 million in 2025, then fell by 2.04% to $38.5 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $38.5 million, $37.8 million, and $39.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.50 Mn |
| Mar 31, 2026 | 37.80 Mn |
| Dec 31, 2025 | 39.30 Mn |
| Sep 30, 2025 | 36.40 Mn |
| Jun 30, 2025 | 37.00 Mn |
| Mar 31, 2025 | 36.30 Mn |
| Dec 31, 2024 | 35.30 Mn |
| Sep 30, 2024 | 37.60 Mn |
| Jun 30, 2024 | 29.60 Mn |
| Mar 31, 2024 | 28.90 Mn |
| Dec 31, 2023 | 32.10 Mn |
| Sep 30, 2023 | 35.70 Mn |
| Jun 30, 2023 | 37.00 Mn |
| Dec 31, 2022 | 21.70 Mn |